INTRODUCTION
Members of the herpesvirus genus have been shown to induce tumours in animals, e.g. Marek's disease herpesvirus which induces lymphomas in chickens, the natural host, and herpesvirus saimiri which induces lymphomas in monkeys which are not the natural host. In these cases and that of Epstein-Barr virus (EBV) which is closely associated with Burkitt's lymphoma and nasopharyngeal carcinoma the virus DNA is maintained in the tumour cells.
For nearly 3 decades herpes simplex virus (HSV) has been associated with cervical carcinoma. More recently human cytomegalovirus (HCMV) has also been implicated in this disease. The early links between HSV and neoplastic disease were based on seroepidemiological studies (for reviews, see Rawls, 1983; Vonka et al., 1984) . Although similar studies with HCMV are controversial, the virus is a venereally transmitted pathogen (discussed by Fletcher et al., 1986) .
The present review explores the latest experimental results which evaluate the roles HSV and HCMV play in oncogenic disease. Previous reviews covering earlier work in this field are by Minson (1984) , Galloway & McDougall (1983) , Tevethia (1983) , Knipe (1982) , Hampar (1981) and Nahmias & Norrild (1980) . This review is divided into five main sections, and for each a comprehensive selection of relevant papers has been tabulated (Tables 1 to 5 ) and the main concepts are discussed in the text for HSV type 2 (HSV-2), HSV type 1 (HSV-1) and HCMV. Section I discusses the ability of the virus to transform cells morphologically to an oncogenic phenotype. Section II considers the induction of tumours in animal model systems. Section III deals with the detection of virus nucleic acid in human tumours. Section IV briefly discusses the association of genital tumours with human papiUomavirus (HPV). Section V examines activation of cellular transcription in both cis and trans as an important mechanism by which herpesviruses alter normal cells. Section I is further divided into eight subsections representing Galloway et al. (1984 Galloway et al. ( , 1985 Jones et aL (1986) Jariwalla et aL (1983) Reyes et aL (1979) Galloway & McDougall (1981 ) Cameron et al.
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Macnab et al. (Peden et al., 1982) and MTRII (Galloway & McDougall, 1983 (1985) . The BC24 fragment (737 bp) is the smallest to transform rat embryo or NIH 3T3 cells in the focus or anchorage independence assay system of Galloway et al. (1984) . The PstI C Sail B fragment is the smallest (480 bp) Jariwalla et al., 1986) found to transform Rat-2 cells in the focus assay system of JariwaUa et al. (1986) . The subfragment of BamHI e labelled H oncogenically transforms hamster cells (Hayashi et al., 1985) .
mechanisms which may be implicated in the induction of morphological transformation and covers features of HSV and HCMV involved in multistage carcinogenesis. These mechanisms are summarized in Tables 1, 2 and 3 for HSV-2, HSV-I and HCMV. Tables 4 and 5 summarize the data On animal model systems and on the detection of virus DNA in human tumours. Duff& Rapp in 1971 and 1973 . Skinner (1976 suggested a 'hit and run' mechanism to describe HSV transformation in which he could not detect the Continuing express!on of HSV DNA. Minson et al. (1976) showed that this was due to the successive loss of HSV DNA sequences on passage of transformed cells. This section examines the different mechanisms by which HSV and HCMV may transform tissue culture cells to an oncogenic phenotype:
I. Morphological transformation of cultured cells Transformation by HSV was first reported by
Three regions of the HSV genome are associated with morphological transformation of cultured cells. One of these (Camacho & Spear, 1978) present in HSV-1 is known as MTRI (morphological transformation region of HSV-1) and maps in XbaI f(0.29 to 0-45 map units, m.u.) and BglII i (0.311 to 0.415 m.u.) (Reyes et al., 1979) . The sequences coding for glycoprotein B (gB) can be at least transiently expressed. In HSV-2 there are two regions of the genome associated with the induction of morphological transformation : these are MTRII (morphological transformation region of HSV-2) mapping (Reyes et al., 1979; Macnab & McDougall, 1980; Galloway & McDougall, 1981 ; Cameron et al., 1985) in BglII n (0-58 to 0.62 m.u.) and another region confusingly referred to as MTRIII (the third morphological transformation region of HSV; Peden et al., 1982) maps in HSV-2 BglII c (0-54 to 0-58 m.u.). Thus only one region inducing transformation is found in HSV-1 whereas two are found in HSV-2. A (Galloway & McDougall, 1983) . The fragment responsible for the activation of endogenous retrovirus is labelled MuX (Boyd et al., 1980) . BamHI g is the fragment shown to be mutagenic in an Ames-type test (Shillitoe et al., 1986) . The transcripts mapping in this region are identified by the major gene product they encode, e.g. TK, Pol (DNA polymerase), DBP (major DNAbinding protein). The transcript mapping was taken from McKnight (1980) and Holland et al. (1984) .
OriL is an origin of replication.
region in the left half of BgllI c can immortalize hamster embryo cells ; this was the original transformation assay used by Jariwalla et al. (1980) to locate transforming functions in the HSV-2 genome. Clear evidence that transformation by HSV leads to oncogenically transformed cells is not in dispute (Galloway & McDougall, 1983; Cameron et al., 1985; Hayashi et al., 1985; . Two facts arising from morphological transformation studies with HSV-2 are also generally accepted. First, small DNA fragments of a size unable to code for a transforming protein may be shown to induce morphological transformation . Second, the DNA used to induce morphological transformation is not necessarily retained within the transformed cell (Galloway & McDougall, 1983; Galloway et al., 1984; Cameron et al., 1985; Jariwalla et al., 1986; R. J. Jariwalla, personal communication; J. C. M. Macnab, unpublished results) and no evidence for the existence of an HSV-coded transforming protein has been found (Cameron et al., 1985) .
HCMV also has two regions of the genome that induce morphological transformation. HCMV strain AD169 induces morphological transformation of rat embryo or NIH 3T3 cells by a 481 bp fragment of HindlII E (Fig. 3, Table 3 ) whereas transformation of hamster embryo or Rat-1 cells has been localized to the BamHI M and J terminal fragments of XbaI E (Clanton et al., 1983) of HCMV DNA (Fig. 3, Table 3 ). These workers originally identified XbaI E by looking for a region of the Towne strain DNA that shared homology with BgllI c of HSV-2 and could rescue cells from senescence and thus transform them. Although virus DNA is not retained in HCMV strain AD169-transformed cells, it is retained in cells transformed by (Oram et al., 1982) shown to be responsible for morphological transformation by HCMV strain AD169. HB1 to HB6 are the BaraHI subfragments of HindllI E. The transcript mapping was taken from Jahn et al. (1984) . The smallest fragment shown to induce transformation (490 bp) (cloned in pCM4127 from strain AD169) is from Galloway et al. (1984) and Nelson et al. (1984) . The strong enhancer described by Boshart et al. (1985) is marked E. The major IE polypeptide (69K/71K) encoded by the abundant 1.9 kb mRNA is sometimes referred to as 75K according to SDS-PAGE but appears on sequencing to be 63.8K (Akrigg et al., 1985) . The transformation region described by Clanton et al. (1983) in strain Towne lies adjacent to but outside the HindIII E transforming region of Nelson et al. (1984) . Mapping data for this fragment were taken from Thomsen & Stinski (1981) and Staprans & Spector (1986) . For AD169 the prototype orientation of the long unique segment used by Nelson et al. (1982 Nelson et al. ( , 1984 and Jahn et al. (1984) is the opposite of that used by Thomsen & Stinski (1982) and Staprans & Spector (1986) . This consequently alters the map coordinates used by these groups.
HCMV strain Towne (EI-Beik et al., 1986) at least at the passage levels examined to date. No transforming function has yet been ascribed to the retained DNA. At the present time the available data implicating HSV and HCMV in oncogenic transformation can be classified under eight headings. These divisions represent mechanisms thought to be associated with the induction of transformation as well as those related to a transforming event. They are not mutually exclusive and one event may require discussion under different headings. The event will usually be discussed in relation to the virus with which most work has been carried out. Tables 1 to 3 contain details and references for HSV-2, HSV-1 and HCMV. The genome map positions (m.u.) involved in the first seven of these events are shown in Fig. 1 , 2 and 3 corresponding to HSV-2, HSV-1 and HCMV.
DNA structures thought to be involved in transformation
The induction of transformed loci by fragments of HSV and HCMV DNA unable to code for proteins suggested that some specific arrangement of DNA in these sequences might initiate transformation. Galloway et al. (1984) proposed that a small stem/loop structure of 737 bp in HSV-2 BgllI n and 490 bp in HCMV HindlIl E bounded by direct repeats may induce morphological transformation (Fig. 4a ). There were three proposed mechanisms, activation of a cellular oncogene, function as an enhancer element or action as a mutagen. Although the stem/loop structure resembles the P elements of drosophila (Rubin, 1983) transformation. In addition, sequences that show homology to the consensus of the Sp! binding site (GGGCGG) described by Kadonaga et al. (1986) are present. suggest that this resembles the control factor of Spl which binds to a GGGCGG sequence. However, in a G + C-rich virus like HSV (some genes contain 80~ G + C) the significance of this GGGCGG hexanucleotide is not clear. In 39000 bp of sequence representing the leftmost portion of the long unique sequence of the HSV-1 genome, the hexanucleotide occurs 113 times, 103 being within predicted protein-coding sequences (D. J. McGeoch, personal communication). It is possible that only a small fraction of these sequences constitute functional SpI binding sites although five such sites do exist in the immediate early (IE) gene 3 promoter. Thus it is possible that the detection of this sequence in a locus of interest may be correlative, rather than of predictive value.
Review: Herpesviruses and tumourigenesis
The significance of DNA structures in putative transforming mechanisms has been assessed by E. J. Shillitoe (personal communication, presented at l lth International Herpesvirus Workshop, 1986 ) who used a computer program to analyse IS-like structures in HSV-2 DNA. The program recognizes IS sequences of prokaryotes as well as other transposable elements, and Shillitoe found sequences similar to IS structures in the transforming sequences of HSV-2. However, such sequences were frequently present in other regions of HSV DNA as well as in randomly shuffled DNA sequences. In fact, so common were qS-type' sequences that their correlation with any function was called into doubt. His results suggest that the IS structure described by Galloway et al. (1984) may not be unique to this transforming fragment of HSV-2 and we must question why the distinctive DNA structures observed by Galloway and Jariwalla are able to transform if other such structures do not.
Proof of a biological function for these DNA structures is required. The predictive value of DNA structures in HSV transformation could be assessed by cloning them into retrovirus vectors and testing their ability to induce morphological transformation when recombined into non-transforming retroviruses.
No claims have yet been made that particular DNA structures are involved in the transforming function ofHSV-1. No DNA ( > 500 bp) from this region is consistently retained in transformed cells (Cameron et al., 1985) .
Role of ribonucleotide reductase
The ribonucleotide reductase (RR) of HSV (Cohen, 1972; Cohen et al., 1974) is possibly essential for virus replication (Dutia, 1983) . It probably consists of two subunits (Bacchetti et al., 1984 (Bacchetti et al., , 1986 Frame et al., 1985) , one large subunit of M~ 140000 (Vmwl40; also described as Mr 136 000, 138 000, 144 000, 160 000 and as ICP6 in HSV-1, ICP 10 in HSV-2) and one small subunit of Mr 38000 (also described as Mr 35000, 40000 and 44000). The large subunit has been shown Flanders et al., 1985) to correspond to AG4 described by Aurelian et al. 2534 J.c.M. MACNAB (1980) . A mutant with a temperature-sensitive (ts) mutation affecting RR encodes a defective Vmwl40 polypeptide (Dutia, 1983; Preston et al., 1984) . Evidence suggests that functional activity of RR depends upon the association of the two subunits (Frame et al., 1985 ; Cohen et al., 1986; Dutia et al., 1986; Bacchetti et al., 1986) . The subunits are encoded by two transcripts whose colinear 3' ends map within the BglII n fragment (Fig. 1 ) of HSV-2 (McLauchlan & Clements, 1983) . The small subunit is completely encoded by the BgIII n fragment; the large subunit is mostly encoded by BglII c but the carboxy terminus lies in BglII n (McLauchlan & Clements, 1983) . The observation by several groups of transformed foci after transfection of subfragments contained within the HindIII a fragment (0.52 to 0.673 m.u.) of HSV-2 which includes both BglII c and BglII n together with the results of Dutia (1983) led Huszar & Bacchetti (1983) to speculate that the RR gene could be involved in transformation. However, these transforming subfragments often lack sequences encoding the amino and carboxy termini of RR. Examples of active domains of particular proteins have been found to be involved in transformation, e.g. the amino terminus of large T antigen (an oncogene) of polyoma virus (Cuzin et al., 1984) but the exact role of any domain of HSV RR cannot at present be explained. A brief survey of experiments involving the transforming sequences reveals the following conclusions.
(a) Experiments im,olving BglH n Galloway et al. (1984) concluded that the 737 bp transforming fragment ofBgllI n does not lie within the coding sequences of the RR gene. Although Cameron et al. (1985) showed transformation with BglII n which encodes the small subunit of RR they detected neither RR activity in the transformed cells nor HSV DNA fragments greater than 500 bp coding for this activity present at a detection level of 0.1 copies per cell.
When HSV ts mutants were used to transform cells (Macnab, 1974 (Macnab, , 1975 (Macnab, , 1976 and unpublished results) all, including HSV-1 tsK, a DNA-negative mutant which produces only the four functional IE polypeptides [Vmw110 (ICP0), Vmw68 (ICP22), Vmw63 (ICP27), Vmwl2 (ICP47)], a non-functional Vmw 175 (ICP4) and Vmw136 (ICP6) (Marsden et al., 1976; Preston, 1979) were very cytotoxic (Schek & Bachenheimer, 1985) in the primary or secondary rat embryo cells used. Cytotoxicity varied from experiment to experiment. This problem, coupled with low efficiency of transformation (e.g. only one focus would result from infection of 2 x 106 cells) made accurate quantification impossible and dose-response curves difficult to obtain. The earliest mutant able to induce a focus was HSV-1 tsD (a DNA-negative mutant). Although it also has a mutation in the IE Vmw175 (ICP4) gene, this lesion is nearer to the carboxy terminus of the protein than is the tsK lesion affecting Vmw175 (Preston, 1981) . As a result tsD can produce some early polypeptides at non-permissive temperature in addition to the IE ones. Both tsK and tsD induce the large subunit of RR but its transforming function has been associated only with established cells Hayashi et al., 1985) . Macnab (1974 Macnab ( , 1975 Macnab ( , 1979 and Cameron et al. (1985) used primary cells, and therefore the large subunit of RR is not likely to be the transforming function.
Van den Berg et al. (1985) did not detect expression of the RR gene after selectable transformation with the BgllI n fragment and the thymidine kinase (TK) gene. Saavedra & Kessous-Elbaz (1985) suggest that the complete Bgl I I n fragment may be 'poisonous' for cells, as its presence actually depresses selectable transformation with the neomycin resistance (neo R) gene. Bejcek & Conley (1986) detected extrachromosomal DNA (Hirt, 1967) after transfection of BglII n sequences with the selectable neo a gene and could rescue as a plasmid a combination of BgIII n sequences and cell sequences with homologies to BglII c. These rescued plasmids could transform cells 1000 times more efficiently than the BgIII n fragment alone. Further analysis of this system will be awaited with great interest as the cell sequence may encode a cellular oncogene. (Hayashi et al., 1985; Iwasaka et al., 1985) , or prostaglandin E2 and protein kinase C activity (Krebs et al., 1987; L. S. Kucera, personal communication, l lth International Herpesvirus Workshop, 1986) . There is no experimental evidence for the direct induction of these activities by any HSV gene. However, the expression of the RR gene was confirmed at least as far as passage 33 by Hayashi et al. (1985) using a monoclonal antibody (MAb) to RR.
The 481 bp fragment of BamHI e which induces the transformation of Rat-2 cells encodes neither the amino nor the carboxy terminus of RR. The catalytic function of the enzyme has been mapped to the carboxy terminus which lies outside the Pst I C transforming region, indicating that RR is not required to induce transformation of Rat-2 cells. In addition, the structurally unique domain of 355 hydrophilic amino acids in RR of HSV-2 (Swain & Galloway, 1986) is not encoded by the transforming DNA fragment.
In conclusion, no requirement for the continuing expression of either the large or the small subunit of RR has been clearly demonstrated in HSV-transformed cells. It has been suggested (S. Bacchetti, personal communication) that the role of RR in transformation may be destabilization of nucleotide pools, but as yet no experimental evidence exists to support or refute this. No transforming role for RR has been proposed for HSV-1 or HCMV.
Biological carcinogenesis
Certain effects of HSV resemble the changes produced by chemical carcinogens when they induce cellular transformation. These cellular DNA alterations can be termed biological carcinogenesis. They do not require the retention of virus DNA sequences and may be subdivided into two specific actions on cellular DNA, mutagenesis and gene amplification.
(a) Mutagenesis Schlehofer & zur Hausen (1982) showed that HSV-1, inactivated by neutral red dye or by ultraviolet light, was mutagenic for the hypoxanthine guanine phosphoribosyl transferase (HGPRT) gene of human rhabdosarcoma cells (RD-176) which are permissive for HSV replication. The mutagenicity of neutral red-inactivated virus was five-to tenfold higher than background and was comparable to the effect of the chemical carcinogen 4-nitroquinoline-1-oxide (4-NQO) which gave a five-to sevenfold increase. Pilon et al. (1985) showed that infection with HSV-2 could increase the mutation frequency of the HGPRT gene by 2.5 to 10-3 times in the non-permissive XC cell line. No evidence of retained HSV DNA sequences was found in the mutant cell lines. The size of the HGPRT transcript and its level of transcription in the mutants was similar to those in the wild-type cell, which suggests that the mutagenic effect exerted by HSV-2 is the result of point mutations rather than gene rearrangements (Pilon et al., 1986) . Such mutagenic activity can be directly compared to the base transition in the H-ras oncogene induced by nitrosomethylurea, a chemical carcinogen (for review, see Notario et al., 1984) . Other studies (Brandt et al., 1987; have shown that introduction of dsDNA mutagenizes the HGPRT gene. They suggest that the pCB24 transforming clone of HSV-2 appears to be more mutagenic than pBR322 itself , implying that the role of pCB24 in transformation might be mutagenesis.This is not supported by statistical evidence at this stage (Brandt et al., 1987) .
Recently, interest in the mechanism by which MTRI transforms cells has been revived and Shillitoe et al. (1986) have addressed the question of mutagenesis. These workers have introduced the BamHI g fragment of HSV-1 into the expression vectors pUC7, pUC8 and pUC9 in both orientations and identified a higher rate (up to 39-fold) of reversion of a frameshift mutation in Escherichia coli C caused by only one of these constructs. This is similar to the Ames test for mutagenic activity (Ames et al., 1975) . Using the argument that many mutagens are also carcinogens, Shillitoe et al. (1986) suggest the existence of a mutagenic peptide of HSV-1 which may be involved in cellular transformation. However, this conclusion relies on sequence data from other HSV-1 strains. Shillitoe et al. (1986) suggest that the peptide is 37 amino acids long, but as six of these arise from the vector the mutagenic viral peptide must be very small. Nonetheless, the test is novel and may lend itself to further adaptations. Mutagenesis may be an important role played by HSV in oncogenesis and the molecular mechanisms deserve further investigation. Similar mutagenic mechanisms have been suggested for the highly oncogenic adenovirus 12 which does not necessarily require maintenance of virus DNA sequences in tumours (Paraskeva et al., 1982) .
(b) Gene amplification
Gene amplification is thought to be an essential step in the alteration of a normal cell to an oncogenic cell (for review, see Schimke, 1982) . HSV-1 can cause amplification of genes in cells in a manner similar to chemical carcinogens (Lavi, 1981) . Schlehofer et al. (1983) used HSV to induce amplification of simian virus 40 (SV40) genes in Chinese hamster embryo transformed cells. Amplification, monitored by in situ hybridization and Southern blot analysis, was more pronounced than that induced by the carcinogen benzo[a]pyrene and similar to that induced by 4-NQO. Because inactivated virus also induced an at least 15-fold amplification it was postulated that amplification was an early event in infection. The degree of increase of DNA synthesis was proportional to the input multiplicity of infection of HSV-1.
The expression of the HSV polymerase gene is important in amplification, which is abolished by drugs acting on the HSV polymerase. That DNA polymerase-negative mutants of HSV-1, e.g. tsH, do not induce amplification suggests that the effect is at least in part due to a viruscoded function (Matz et al., 1984) . Moreover, antisera to HSV inhibit gene amplification. Amplification also involves a cellular component, being dependent on the cell line used (Matz et al., 1984 (Matz et al., , 1985 Heilbronn et al., 1985) . Inhibitors ofDNA polymerase ~ such as aphidicolin also inhibit gene amplification (Heilbronn et al., 1985) .
HSV-1 and HSV-2 have been shown to amplify HPV-18 DNA sequences integrated in HeLa, C4-1 and C4-11 cells by two-to eightfold over background (Brandt et al., 1986) . The cells used by Brandt et al. were derived originally from tumours of the cervix which were already malignant. In this case HSV-2 obviously acts at a late stage in carcinogenesis and not at the level of initiation.
Increased or altered expression of cellular genes
The work reported by Cameron et al. (1985) suggested that no virus-coded protein was expressed in a range of HSV-1-and HSV-2-transformed cells, on the basis of Southern blot analysis. One result, previously interpreted as the continuing expression of HSV functions in transformed cells (Macnab, 1974 (Macnab, , 1975 (Macnab, , 1979 Bfifiltjens & Macnab, 1981) remained to be explained. When cells were initially transformed they formed a focus, which was subcultured and the cells were tested for immunofluorescence. Initially only a small proportion showed strong immunofluorescence with antisera raised against HSV-infected cells, but all transformed cells went through a crisis phase as previously described (Macnab, 1974) during which most of the cells died and the remaining viable cells eventually multiplied and formed a stable culture. At this point all the transformed cells showed cytoplasmic and perinuclear immunofluorescence with sera raised against HSV-infected rat embryo cells, suggesting that the remaining cells were a subpopulation that had become established or immortalized in culture (Macnab, 1974 (Macnab, , 1975 (Macnab, , 1979 Bfifiltjens & Macnab, 1981 ; J.C.M. Macnab, unpublished results). When the specificity of this fluorescence was tested utilizing a battery of MAbs to HSV-coded proteins (kindly made available by Drs A. Cross and J. Palfreyman) in direct and indirect fluorescence tests and also for HSV surface antigens by use of a fluorescence-activated cell sorter, no HSV-coded polypeptides could be detected consistently in the transformed cells. Antisera against HSV-infected cells did immunoprecipitate several polypeptides from HSVtransformed cells (Macnab et al., 1985a) which could not be immunoprecipitated from untransformed control primary or secondary rat embryo cells. Several polypeptides of similar Mr were immunoprecipitated when sera of turnout-bearing rats were used (Macnab et at., tested and immortalized rat cells showed similar patterns of immunoprecipitation with this antiserum. TG7A did not immunoprecipitate similar polypeptides from primary or secondary rat embryo cells. Thus immortalization, conversion to longevity or the establishment of a primary cell into continuous cell culture were associated with immunoprecipitation of cellular polypeptides by TG7A. Peptide mapping confirmed that these 90000, 40000 and 32000 Mr polypeptides were indistinguishable from cellular polypeptides (Macnab et al., 1985 a). Walker et al. (1985 have suggested that transfection of dsDNA itself may play a role as a cellular regulatory signal but whether this regulatory signal is similar to those induced by HSV infection remains to be established (Macnab et al., 1985a) . Walker et al. suggested that HSV infection may thus initiate an event which facilitates later stages of the multistage process involved in the emergence of an oncogenic cell. The identification of these cellular polypeptides in cDNA and genomic libraries constructed from HSV-infected and transformed rat embryo cells should yield cloned genes which may be directly tested in molecular studies on HSV regulation.
The mechanism of host cell interaction (involved in initiation of transformation) described by Macnab et al. (1985a) is the first report of a specific gene product induced after infection with HSV in which the induced gene continues to be expressed in the transformed cell. The increased expression of cellular genes is similar to oncogene studies in which cellular proto-oncogenes are upregulated (for review, see Hunter, 1984) .
The mechanism by which pCM4127, containing a cloned 490 bp fragment of HCMV, initiates transformation (Nelson et al., 1982) has been further examined by McDougall et al. (1985) , Galloway et al. (1985) and Buonaguro et al. (1987) . The pCM4127 clone was cotransfected with the plasmid pSV2neo containing the neo R selectable marker. Cloning of mouse unique and repetitive DNAs flanking pCM4127 (in phage 2 libraries) showed that the transcription of a unique fragment was increased five-to tenfold in the transformed line compared to that in the normal NIH 3T3 line. Additionally, in a transient expression assay pCM4127 could increase transcription of the chloramphenicol acetyltransferase gene. Galloway et al. (1985) conclude that the IS-like sequence they propose as being involved in transformation by HCMV acts as an enhancer. However, this enhancer is distinct (Fig. 3, CM4127 ) from the strong enhancer element (Boshart et al., 1985) located upstream (Fig. 3, E) Workshop, 1986 ) have identified several clones in cDNA libraries representing mRNAs transcribed at increased levels after HSV-2 transformation. Southern blotting suggests only one gene is involved. It is not known whether this gene is also regulated differently after HSV-2 infection.
Activation of endogenous viruses
The ability of HSV to activate endogenous retrovirus from cells is not in itself attributable to a transformation function. However, it is clearly a very interesting property. It is now some time since the activation by HSV infection of an endogenous C-type virus (MuX) from a feline cell line (F81) transformed by the Moloney strain of murine sarcoma virus was reported (Hampar et al., 1976; Boyd et al., 1978) . This activation is an intriguing observation and its relevance as a model system for activation of endogenous viruses in tumours has never been fully explored.
Specific HSV-1 DNA sequences were shown to be responsible for the induction of MuX (Boyd et al., 1980) in a line of BALB/c mouse cells. These sequences which map within the HSV-1 fragment responsible for morphological transformation (MTRI) are said by Shillitoe et al. (1986) to be distinct from the mutagenic BamHI g fragment, the DNA polymerase gene and the HSV TK gene (Fig. 2) . The MuX-inducing sequences map to the left ofBamHI g and the DNA polymerase gene maps to the right (Fig. 2) . Boyd et al. (1980) suggest the mechanism involved in induction is co-carcinogenesis. Minson (1984) considered the MuX function to be the result of mutagenesis. However, activation via integration of a promoter or enhancer element of HSV is another possibility.
Identification of this MuX function depends on the use of a cell line that forms distinct loci (syncytia) after activation of the endogenous C-type retroviruses by infection with HSV. The J.c.M. MACNAB MuX activation function mapped within coordinates 0-29 to 0.32 and Boyd et al. (1980) showed that it was inactivated by digestion with endonucleases that cut in the TK gene, although the possible function of TK in induction of the endogenous viruses is unclear. Other regions of the HSV-1 genome, located within 0-46 to 0.49 and 0-92 to 0-97 m.u, will similarly reactivate endogenous virus but the mechanism has not yet been elucidated.
HCMV DNA has been shown to activate endogenous viruses from BALB/c cells (Boyd et al., 1978) . Because HCMV cannot replicate in these cells and presumably induces mainly IE polypeptides, we must assume that either an IE gene product or a promoter or enhancer sequence is involved in this activation.
It is possible that as yet unidentified retroviruses may be involved in genital neoplasia and further studies on endogenous virus reactivation from cervical intraepithelial neoplasias (CIN) and cancers might reveal transforming RNA viruses.
Coding capacity of HSV for a protein kinase
Recent work by McGeoch & Davison (1986) has shown that sequences contained within the U3 region of both HSV-1 and HSV-2 can code for a protein kinase of postulated Mr 53000 with some homology to v-src. Since a protein kinase activity is closely associated with oncogenic transformation, being the product of several oncogenes e.g. v-src, v-yes, v-abl, v-fos (for review, see Hunter, 1984) , we associate this function with oncogenic cells. However, no group has yet isolated transforming activity arising from the short unique region of the HSV genome. An unmapped protein kinase activity has also been described by Purves et al. (1986) and by Lemaster & Roizman (1980) . Cytomegalovirus has been shown to code for a protein kinase of Mr 68000 (Michelson et al., 1984) . A major phosphorylated protein gene has been mapped to the long unique region of HCMV (Davis et al., 1984; Davis & Huang, 1985) . McGeoch & Davison (1986) have shown that there is no DNA homology among the protein kinases of HSV, varicellazoster virus and HCMV.
7. Homology of HSV-2, HSV-1 and HCMV DNA with cell DNA sequences Although homology at the level of virus/cell DNA sequences has not been cited as a mechanism by which HSV may transform cells, it is clear that homologous DNA sequences provide a mechanism by which the virus may integrate into the host cell by homologous recombination. Such recombination may be involved in the enhancement of cellular gene activity or in the deregulation of genes encoding polypeptides important in cellular control.
In the case of HSV-1, considerable homology has been detected in the long (L) and short (S) inverted and terminal repeat regions of the genome (Table 2) to both human and mouse cell DNA (Peden et al., 1982; Gomez-Marquez et al., 1985; Spector et al., 1987) . This homology is not due to G + C-rich sequences as suggested by Jones & Hyman (1983) . Jones et al. (1985) and Parks et al. (1986) have shown homology between human 28S RNA and HSV DNA from the inverted repeat region of the L segment. In HSV-2 (Table 1) homology between mouse and human cell DNAs and the L and S inverted repeat regions as well as the centre of the L region has been reported (Peden et al., 1982; Jariwalla et al., 1986) . HCMV also exhibits host/virus DNA homology (Peden et al., 1982;  Table 3 ). One other property of herpes viruses which cannot be overlooked when examining means by which they transform cells is latency.
Latency and transformation by HSV-1, HSV-2 and HCMV
A study of transformation should preferably not be complicated by latency. Morphological transformation is often beset by the problem that viruses which transform cells can be maintained latently or persistently within these cells. This is certainly true for SV40 as well as adenovirus 12, EBV and other lymphotropic herpesviruses.
Our studies showed that we could reactivate HSV from a few cells in different HSVtransformed lines even after 18 months in culture (Park et al., 1980) or after 18 months latency or persistence in the rat . This latency is different from the model of latency in vitro of Russell & Preston (1986) . HCMV can remain latent in tissues and can be reactivated 
* NA, Not applicable.
by various means, e.g. immunosuppression. The site of latency may be lymphocytes, leukocytes or fibroblasts and transformation of prostatic cells by the Mj strain of HCMV has been reported by Rapp et al. (1975) after virus was isolated from these cells. It is known that HCMV induces host macromolecular synthesis (for review, see Huang et al., 1984) . The induction of cellular polypeptides as a result of HSV or HCMV latency has not been studied but its relevance to transformation warrants further investigation to understand whether latency is involved in the multistage process of carcinogenesis, perhaps at the level of initiation. The data covered to this point deal with mechanisms potentially involved in morphological transformation of cells. We will now consider how HSV and HCMV may be involved in preneoplastic and neoplastic disease in animals.
II. Animal models
To test the hypothesis that HSV could be a cofactor in the progression to oncogenesis Burns & Murray (1981) demonstrated that after treatment with both 12-O-tetradecanoylphorbol-13-acetate (TPA) and u.v.-inactivated HSV-1, papilloma lesions of the mouse lip will progress to carcinomas. Unfortunately, no further details of this interesting system have been published. However, Wentz et al. (1981) have pursued an interesting mouse model for cervical cancer. In the first instance they showed that u.v.-inactivated HSV-1 and HSV-2 applied to the cervix could induce cervical cancers about twice as frequently as formalin-inactivated virus. Both premalignant (dysplasia) and malignant lesions were induced. Prior immunization of the mice with HSV-1 prevented both dysplasia and carcinomas (Wentz et al., 1983) . More recent studies have shown that HSV-2 DNA, or HSV-2 DNA cleaved with the endonuclease BglII, will also induce dysplasia and carcinomas in mice (D. D. Anthony et al., personal communication, 1 lth International Herpesvirus Workshop, 1986) . HEp-2 cell DNA or calf thymus DNA used as controls did not produce dysplasia or carcinomas. Although the treatment (three times weekly for 80 to 100 weeks) appears traumatic the lack of dysplasia or carcinomas in mice similarly treated with control DNAs suggests some specific role for HSV-2 DNA. Similar types of investigation (Chen et al., 1986) have been carried out in China in conjunction with the Skinner vaccine (for reference, see Skinner et al., 1987 ). Skinner's group has produced a subunit vaccine against HSV-2 and Chen has used it to protect mice against the development of cervical carcinoma after the application of HSV-2 to the cervix. The 50~o incidence of positive carcinomas induced could be reduced to 19~/o if the animals had been previously immunized with the vaccine (Chen et al., 1986) . In contrast, studies by Meignier et al. (1986) 
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Fletcher ( Heggie et al. (1986) have also treated mice with u.v.-inactivated HCMV for 70 to 90 weeks. Dysplasia arose in 51% and carcinomas in 10~ whereas the control mice showed 3% with dysplasia and carcinoma in none. Thus the induction of preneoplastic and neoplastic disease by HCMV was similar to the induction by HSV-1 and HSV-2. These studies (summarized in Table 4 ) suggest that some HSV-or HCMVcoded gene is involved in the induction of tumourigenesis.
III. Involvement of HSV and HCMV with human tumours
That HSV and HCMV can and do infect the cervix is evidenced by the presence of virus DNA sequences in a small percentage of histologically abnormal cervices (Table 5 ). The detection of restriction endonuclease sites colinear with virion DNA Fletcher et al., 1986) adds weight to the validity of these studies. The subsequent molecular cloning of HCMV DNA sequences into phage 2 (J. C. M. Macnab & K. Fletcher, unpublished results) further confirms this association. In this study HCMV DNA sequences were identified in clones of an EMBL3 library (Fletcher, 1986) constructed from CIN DNA. Regions representing the major enhancer sequences (Boshart et al., 1985) , the major IE gene Akrigg et al., 1985) and those sequences initiating morphological transformation (Kouzarides et al., 1983; Nelson et al., 1984) were detected. Table 5 illustrates the fact that different regions of the HSV genome have been detected in CIN and tumours. Such sequences may represent regions of the virus associated with biological functions, e.g. HSV polymerase/gene amplification or the HCMV strong enhancer (which could function like the promoter insertion sequence of avian myeloblastosis virus; Hayward et al., 1981) . Thus, these viruses could contribute to the transformed phenotype in a small percentage of disease cases but the detection of retained virus DNA sequences suggests that the mechanisms involved in transformation of fibroblastic cells in vitro are different from the natural progression of HSV and HCMV infection of epithelial target cells in vivo. This difference is not at present understood but it is clear that preferential growth of the virus in cells would result in all regions of the virus genome being equally represented in the various tissues. That this is not the case (Fletcher et al., 1986) suggests that they have either some as yet unidentified significance in human disease or that their presence is merely fortuitous and may be misleading.
The use of polyclonal antisera which contain antibodies to cellular as well as virus-coded polypeptides (Macnab et al., 1985a) , the homology between virus and cell DNA sequences (Tables 1, 2 , 3) and the confusing amplification and rearrangement in transformed and tumour cells of cellular DNA sequences with homology to the plasmid vector pBR322 (Park, 1983; Macnab et al., 1984 Macnab et al., , 1985b Macnab et al., , 1986 Cameron et al., 1985; Fletcher, 1986 ; J. C. M. Macnab, unpublished results) are all major factors which have led to a plethora of confusing findings in the association of HSV and HCMV with both transformed cells and human histologically abnormal tissue.
These points should be borne in mind when evaluating the data on the association of HCMV with tumours, particularly Kaposi's sarcoma (for review, see Huang et al., 1984) , the presence of HSV DNA homologous to mRNA in CIN (Jones et al., 1979; McDougall et al., 1980; Eglin et al., 1981) and tumours (McDougall et al., 1982) , and the homology of HCMV with the oncogene v-myc (Getmann et al., 1983; Spector & Vacquier, 1983) which defied confirmation at the sequencing level (Kouzarides et al., 1983; Minson, 1984) but appeared to be due to G + C-rich regions of DNA (Rasmussen et al., t985) .
Analyses of transformed and turnout cell DNAs and human tumours with a strong association with HSV and HCMV infections prompts the question 'does virus DNA need to be retained in order that a virus may play some role in multistage carcinogenesis?' One virus most certainly retained in a high proportion of tumour cells is HPV.
IV. HPV: its role in genital tumours
The first indication that wart-like lesions could be associated with CIN came from the work of Meisels & Fortin (1976) . This work was further confirmed by immunological evidence of papillomavirus infection (Woodruff et al., 1980 Crum et al., 1984; Prakash et al., 1985; Macnab et al., 1986) . However, studies have also shown that HPV-16 can be present in a large proportion of histologically normal tissues , demonstrating that the mere presence of the HPV genome is not sufficient to induce a cell to become tumourigenic. Kreider et al. (1985) have shown that cell-free extracts of condylomata acuminata (CA) can transform cells of the uterine cervix when grafts are placed beneath the renal capsule of nude athymic mice. The only evidence of transformation of the cervical cells to dysplastic cells arose when they were treated with cell-free extracts of CA. These cells had HPV group-specific antigen and DNA samples hybridized with DNA of HPV-6 and -11, the viruses detected in the original CA. Control experiments consisting of treatment of cervical cells with HSV or mock treatment with no virus did not induce dysplasia, indicating that HSV could not transform in vivo. However, the HPV genome from the CA that did transform was not purified prior to use and may have contained other factors involved in cell proliferation. This is however a most interesting way of propagating HPV and is probably the only successful method published for HPV transformation in vivo.
Zur Hausen has suggested that HPV is not the only cause of cervical cancer and has proposed (zur Hausen, 1982) a synergistic role for HSV in the development of malignant disease. Studies with the Shope rabbit papillomavirus and bovine papillomaviruses show that the geographical area where the turnout is found may contain a co-carcinogen (e.g. bracken in Scotland) which is necessary for conversion of warts to oncogenicity. Furthermore, although HPV-5 and -8 are frequently isolated from skin carcinomas in patients with epidermodysplasia verruciformis, these viruses normally require a co-carcinogen (u.v. light) or an impaired immune response to convert them to oncogenicity (discussed by Pfister et al., 1985; Orth, 1986) . The virus proposed by zur Hausen to act synergistically with HPV is HSV. The role HSV or HCMV may play at the molecular level in the control of gene expression will now be assessed.
V. Molecular studies which suggest a role for HSV or HCMV in carcinogenesis
Both HSV and HCMV can alter transcription of both viral and cellular genes. The IE gene products of HSV, Vmw175 (ICP4) and Vmw110 (ICP0), stimulate transcription of early HSV genes (Everett, 1984; O'Hare & Hayward, 1985) and can also stimulate transcription from plasmid-borne cellular promoters in short term transfection assays (Everett, 1984 : Everett & Dunlop, 1984 . HCMV can also activate transcription of HSV and cellular promoters in a similar fashion (Everett, 1984; Everett & Dunlop, 1984) . The/? and ~ promoters may also be transactivated by IE HSV gene products in cells in which the globin promoter has been stably integrated into cell DNA as a result of selectable transformation using the TK gene (Everett, 1985) . It has been suggested that some cellular genes may be susceptible to transactivation providing certain criteria are met. First, the cellular promoter to be activated must be in an accessible or open region of chromatin. Thus, the failure to activate the rabbit ]~-globin gene during infection of rabbit kidney cells by HSV-1 may be explained if differentiation has resulted in the localization of this gene into tightly packed chromatin (Everett, 1985) . Second, it is possible that only those genes with normal TATA box-dependent promoters are likely to be activated (Everett, 1987 and personal communication) . Since the chromatin configuration of preneoplastic or neoplastic cells is not normal it is possible that transactivation may affect transcription of cellular genes in these cells in a different way from that of normal cells.
Although the stimulation of cellular DNA, RNA and protein synthesis by HCMV has been known for a long time (for review, see Huang et al., 1984 ) the molecular mechanisms of stimulation are not yet understood. Spaete & Mocarski (1985) suggest that HCMV codes for a protein which corresponds to the virion protein Vmw65 of HSV (Campbell et al., 1984) . The Vmw65 can stimulate transcription of the IE genes of HSV. However, the presence of a Vmw65-like polypeptide in HCMV is controversial. Stinski & Roehr (1985) provide evidence that a component of HCMV will activate HCMV IE genes in trans in situations where HSV will not do this. The Mr 89000 IE polypeptide of murine cytomegalovirus activates cellular transcription (Koszinowski et al., 1986) .
Conflicting results reported on DNA sequences necessary for transcriptional activation are probably in part due to the use of different cell systems which contribute different cellular factors to the assays, e.g. epithelial as opposed to fibroblastic cells or cells derived from different species. This problem of cell differences is well known to workers in the morphological transformation field. For instance, understanding of the polyoma T antigens was dependent not only on the cloning of Kamen but also on the necessity to define cell types and growth conditions (Cuzin et al., 1984) . Cell type differences are highlighted by a ts mutant of vesicular stomatitis virus which can alter HeLa cells to cause tumours in nude mice and in another way make BHK C13 cells susceptible to attack by natural killer cells (VandePol & Holland, 1986) .
A cell may become neoplastic by increased expression of a normal cellular proto-oncogene (reviewed by Hunter, 1984) . It is therefore reasonable to suggest that HSV and HCMV may alter a normal cell by increasing transcription of cellular genes. The activation of cellular genes, in their natural environment, by HSV or HCMV infection has been studied in several systems. Notarianni & Preston (1982) showed that heat shock proteins were induced to accumulate after HSV infection and LaThangue et at. (1984) confirmed, using MAbs, their induction after HSV-2 infection. As has been described above, Macnab et al. (1985 a) observed that infection with HSV could induce the accumulation of certain cellular polypeptides in all transformed and established cell lines tested. Patel et al. (1986) identified for the first time a cDNA clone representing a cellular transcript of which the increased transcription was under the control of HSV infection. HSV enhancer activity of the region between genes IE3 and IE4/5 has been confirmed by using it to replace the H-ras 1 oncogene enhancer . The major enhancer of HCMV will increase transcription of cellular genes (Boshart et al., 1985) . These last two experiments confirmed that herpesvirus enhancers may function with cellular genes. Such interactions may be of great importance in cell behaviour during the progression of carcinogenesis.
CONCLUSIONS
In this review it is argued that HSV and HCMV transform cells in vitro to an oncogenic phenotype but that the mechanism by which small pieces of virus DNA carry out this function has not yet been determined. Because these viruses do not encode an oncogene their most convincing roles are their ability to mutagenize cells, to amplify cellular DNA sequences, to induce endogenous retrovirus replication and to switch on host cell proteins not normally, or at least differently, expressed. In the last role the property of transcriptional activation may be of particular importance.
Both HSV and HCMV can be shown to induce cervical tumours in mice. The evidence is persuasive that some HSV or HCMV function induces tumourigenesis. Our current knowledge of host factors that contribute to the eventual phenotype of a cell infected with a virus or transfected with DNA sequences may make us question the validity of animal model systems for defining tumour viruses in human neoplastic disease. Both HSV and HCMV DNA sequences can be demonstrated in human genital preneoplastic and neoplastic disease. However, these sequences either represent regions of the genome capable of inducing different cellular responses involved in tumourigenesis or are merely retained evidence of virus infection in epithelial cells unlike the fibroblast cells used in most transformation assays. If the virus DNA sequences do have a role in tumourigenesis in vivo then we have not yet identified it. The presence of HPV DNA sequences, although strongly associated with cervical neoplasia, is not
